REFERENCES
- Nisell H, Palm K, Wolff K. Prediction of maternal and fetal complications in preeclampsia. Acta Obstet Gynecol Scand 2000; 79:19–23.
- Villar J, Say L, Gülmezoglum M, Merialdi M, Lindheimer M, Betran A, . Eclampsia and pre-eclampsia: a worldwide health problem for 2000 years. In: Critchley H, Maclean A, Poston L, Walter J, editors. London: RCOG Press; 2003:189–207.
- Villar J, Carroli G, Woydyla D, Abalos E, Giordano D, Ba'aqueel H, Preeclampsia, gestational hypertension and intrauterine grouth restriction, related or independent conditions?. Am J Obstet Gynecol 2006; 194:921–931.
- Foy R, Ramsay CR, Grimshaw JM, Penney GC, Vale L, Thomson A, Greer IA. The impact of guidelines on mild hypertension in pregnancy: time series analysis. BJOG 2004, 111:765–770.
- Xiong X, Fraser WD. Impact of pregnancy-induced hypertension on birth weight by gestational age. Ped Perinatal Epidemiol 2004; 18:186–191.
- Westergaard JG, Teisner B, Grudzinskas JG. Serum PAPP-A in normal pregnancy: relationship to foetal and maternal characteristics. Arch Gynecol 1983; 233:211–215.
- Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000, 107:1265–1270.
- Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy associated plasma protein A and the risk of intrauterine growth restriction, premature birth, pre-eclampsia and stillbirth. J Clin Endocrinol Metab 2002; 87:1762–1767.
- Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002; 22:778–782.
- Yaron Y, Ochshorn Y, Heifetz S, Lehavi O, Sapir Y. Orr-Urtreger A. First trimester maternal serum free human chorionic gonadotrophin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther 2002; 17:352–356.
- Kwik M, Morris J. Association between first trimester pregnancy associated plasma protein A and adverse pregnancy outcome. Aust N Z J Obstet Gynaecol 2003; 43:438–442.
- Krantz D, Goetzl L, Simpson JL. Assotiation of extreme first trimester free human chorionic gonadotropin beta, pregnancy associated plasma protein A and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004; 191:1452–1458.
- Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992; 304:867–869.
- Piazze J, Ancesci MM, Cerekja A, La Torre R, Pala A, Papa A, Cosmi EV. Nuchal translucency as a predictor of adverse pregnancy outcome. Int J Gynaecol Obstet 2007; 98:5–9.
- Brambati B, Tului L, Bonacchi I, Shrimanker K, Suzuki Y, Grudzinskas JG. Serum PAPP-A and free β-hCG are first trimester screening markers for Down syndrome. Prenat Diagn 1994; 14:1043–1047.
- Hurley PA, Ward RHT, Teisner B, Isles RK, Lucas M, Grudzinskas JG. Serum PAPP-A measurement in first trimester screening for Down's syndrome. Prenat Diagn 1996; 13:903–908.
- Bersinger NA, Keller PJ, Nalem A, Fischer M, Schneider H. Pregnancy-specific and pregnancy-associated proteins in threatened abortion. Gynecol Endocrinol 1987; 1:379–384.
- Conover CA, Oxvig C, Overgaard MT, Christiansen M, Giudice LC. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein. A. J Clin Endocrinol Metab 1999; 84:4742–4745.
- Lawrence JB, Oxvig C, Overgaard MT. The insuline-like growth factor (IGF) dependent IGF binding protein 4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96:3149–3153.
- Laursen LS, Overgaard MT, Soe R, Pregnancy associated plasma protein A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF. implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS 2001 2001; 504:36–40.
- Clemmons DR. Role of insuline-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 1998; 140:19–24.
- Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999; 14:S90–S96.
- Conover CA, Bale LK, Overgaard MT. Metalloproteinases pregnancy-associated plasma protein. A is a critical growth factor during fetal development. Development 2004; 131:1187–94.
- Pijnenborg R, Bland JM, Robertson WB, Brosens L. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4:397–413.
- Khon GT, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93:1049–1059.
- Kam EPY, Gardner L, Loke YW, King A. The role of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod 1999; 14:2131–2138.
- Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the intrauterine growth retardation and pre-eclampsia. Biol Reprod 2003; 69:1–7.